Home
Conditions
Neoplasm, Residual

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

207 public trials 79 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Not yet recruiting

Blood-Based Minimal Residual Disease in Advanced Epithelial Ovarian Cancer After 1st Line Therapy

NCT07670962

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant

NCT07572929

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +14 more
Locations: Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Not yet recruiting

Proof of Concept for Real-time Multicentric Monitoring of MRD by PET and ctDNA in Aggressive B-Cell Lymphomas

NCT07514715

Conditions: Aggressive B-cell Lymphomas, Neoplasm, Residual, Neoplasms, +3 more
Locations: CHU D'AMIENS - HOPITAL SUD - Service Hématologie Clinique et Thérapie Cellulaire Amiens, France

CHU D'ANGERS - Service des Maladies du Sang Angers, France

CH D'AVIGNON - HOPITAL HENRI DUFFAUT - Service d'Onco-Hématologie Avignon, France

CHU JEAN MINJOZ - Service Hématologie Besançon, France

View all 30 locations

View Trial Details

Not yet recruiting

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

NCT07517705

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Fred & Pamela Buffet Cancer Center Omaha, Nebraska, United States

View Trial Details

Not yet recruiting

Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients

NCT07247201

Conditions: Carcinoma, Head and Neck Neoplasms, Maximum Tolerated Dose, +19 more
Locations: Singapore General Hospital Singapore

View Trial Details

Not yet recruiting

TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

NCT07454486

Conditions: Adenocarcinoma, Biliary Tract Cancer (BTC), Biliary Tract Cancer (CCA), +28 more
Locations: Aarhus University Hospital Aarhus, Denmark

View Trial Details

Not yet recruiting

Treatment for Ph-negative ALL for Adults up to 65 Years

NCT07443592

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Hospital de A Coruña A Coruña, Spain

Hospital Universitario de Araba Alava, Spain

Hospital General Universitario de Albacete Albacete, Spain

Hospital General Universitario Dr. Balmis Alicante, Spain

View all 95 locations

View Trial Details

Not yet recruiting

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

NCT07413146

Conditions: Colon Cancer (Stage II &Amp; III), Colonic Diseases, Colonic Neoplasms, +16 more
Locations: Not specified

View Trial Details

Not yet recruiting

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

NCT07382505

Conditions: Cervical Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +16 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Not yet recruiting

Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC

NCT07350824

Conditions: Disease Attributes, HCC, Minimal Residual Disease, +6 more
Locations: Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Neoplasm, Residual

Neoplasm, Residual trial results

Related conditions